
A new pill specifically designed to prevent migraines appears to do the job, a new clinical trial finds. Atogepant cut patients’ migraine days in half over 12 weeks of treatment, without causing serious side effects, the researchers said. Experts said the drug, if approved by the U.S. Food and Drug Administration, would give migraine sufferers… read on > read on >